BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 9555124)

  • 1. Current concepts of tumor-induced angiogenesis.
    Paku S
    Pathol Oncol Res; 1998; 4(1):62-75. PubMed ID: 9555124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanisms of cancer angiogenesis].
    Sacewicz I; Wiktorska M; Wysocki T; Niewiarowska J
    Postepy Hig Med Dosw (Online); 2009 Apr; 63():159-68. PubMed ID: 19502677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological aspects of angiogenesis in experimental liver metastases.
    Paku S; Lapis K
    Am J Pathol; 1993 Sep; 143(3):926-36. PubMed ID: 7689793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First steps of tumor-related angiogenesis.
    Paku S; Paweletz N
    Lab Invest; 1991 Sep; 65(3):334-46. PubMed ID: 1716330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Angiogenesis in tumors. Part I. Its role in the determination of biological characteristics of tumors; factors controlling the onset and development of angiogenesis].
    Ryska A
    Cesk Patol; 2000 Jan; 36(1):26-31. PubMed ID: 10838755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of vascularization in murine models of primary and metastatic tumor growth.
    Bugyik E; Renyi-Vamos F; Szabo V; Dezso K; Ecker N; Rokusz A; Nagy P; Dome B; Paku S
    Chin J Cancer; 2016 Feb; 35():19. PubMed ID: 26873579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct contributions of angiogenesis and vascular co-option during the initiation of primary microtumors and micrometastases.
    Zhao C; Yang H; Shi H; Wang X; Chen X; Yuan Y; Lin S; Wei Y
    Carcinogenesis; 2011 Aug; 32(8):1143-50. PubMed ID: 21515914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts.
    Inai T; Mancuso M; Hashizume H; Baffert F; Haskell A; Baluk P; Hu-Lowe DD; Shalinsky DR; Thurston G; Yancopoulos GD; McDonald DM
    Am J Pathol; 2004 Jul; 165(1):35-52. PubMed ID: 15215160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-angiogenic tumours and their influence on cancer biology.
    Donnem T; Reynolds AR; Kuczynski EA; Gatter K; Vermeulen PB; Kerbel RS; Harris AL; Pezzella F
    Nat Rev Cancer; 2018 May; 18(5):323-336. PubMed ID: 29520090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
    Shinkaruk S; Bayle M; Laïn G; Déléris G
    Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of angiogenesis in experimental brain metastases.
    Bugyik E; Dezso K; Reiniger L; László V; Tóvári J; Tímár J; Nagy P; Klepetko W; Döme B; Paku S
    J Neuropathol Exp Neurol; 2011 Nov; 70(11):979-91. PubMed ID: 22002424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.
    Prewett M; Huber J; Li Y; Santiago A; O'Connor W; King K; Overholser J; Hooper A; Pytowski B; Witte L; Bohlen P; Hicklin DJ
    Cancer Res; 1999 Oct; 59(20):5209-18. PubMed ID: 10537299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of endothelial Cdk5 reduces tumor growth by promoting non-productive angiogenesis.
    Merk H; Zhang S; Lehr T; Müller C; Ulrich M; Bibb JA; Adams RH; Bracher F; Zahler S; Vollmar AM; Liebl J
    Oncotarget; 2016 Feb; 7(5):6088-104. PubMed ID: 26755662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tumor angiogenesis].
    Lukesová S; Kopecký O; Dvorák J; Hlávková D; Vroblová V
    Vnitr Lek; 2006 Sep; 52(9):797-800. PubMed ID: 17091603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasculogenesis and angiogenesis.
    Patan S
    Cancer Treat Res; 2004; 117():3-32. PubMed ID: 15015550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro tumor angiogenesis assays: plasminogen lysine binding site 1 inhibits in vitro tumor-induced angiogenesis.
    Barendsz-Janson AF; Griffioen AW; Muller AD; van Dam-Mieras MC; Hillen HF
    J Vasc Res; 1998; 35(2):109-14. PubMed ID: 9588874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of tumor growth by basement membrane: modulation of growth and angiogenesis by laminin-derived synthetic peptides.
    Kibbey MC; Yamamura K; Jun SH; Grant DS; Kleinman HK
    Cancer Treat Res; 1994; 71():267-75. PubMed ID: 7524594
    [No Abstract]   [Full Text] [Related]  

  • 18. Continuous and discrete mathematical models of tumor-induced angiogenesis.
    Anderson AR; Chaplain MA
    Bull Math Biol; 1998 Sep; 60(5):857-99. PubMed ID: 9739618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis: an update.
    Díaz-Flores L; Gutiérrez R; Varela H
    Histol Histopathol; 1994 Oct; 9(4):807-43. PubMed ID: 7534514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consequences of angiogenesis for tumor progression, metastasis and cancer therapy.
    Rak JW; St Croix BD; Kerbel RS
    Anticancer Drugs; 1995 Feb; 6(1):3-18. PubMed ID: 7538829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.